Cargando…
Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
Etoricoxib is a non-steroidal anti-inflammatory drug with high selectivity for cyclooxygenase 2 (COX-2), exerting a pronounced anti-inflammatory effect with fewer adverse events when compared to COX-1 inhibitors. The present study aimed to evaluate the bioequivalence between two etoricoxib-coated ta...
Autores principales: | Meulman, Jessica, Davanço, Marcelo Gomes, Vianna, Débora Renz Barreto, da Silva, Thalita Martins, Costa, Fernando, Pacheco, Fernando Bastos Canton, de Oliveira, Milla Emke, Vespasiano, Celso Francisco Pimentel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675291/ https://www.ncbi.nlm.nih.gov/pubmed/38004548 http://dx.doi.org/10.3390/pharmaceutics15112569 |
Ejemplares similares
-
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
por: Davanço, Marcelo Gomes, et al.
Publicado: (2023) -
Optimization of Fast Dissolving Etoricoxib Tablets Prepared by Sublimation Technique
por: Patel, D. M., et al.
Publicado: (2008) -
Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022) -
Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets
por: Brioschi, Tatiane Maria de Lima Souza, et al.
Publicado: (2013) -
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
por: Chen, Yu-Luan, et al.
Publicado: (2023)